{
    "nctId": "NCT03243877",
    "briefTitle": "Performance of MammoAlert\u2122, Point of Care System, for the Screening of Breast Cancer in Women 18 Years of Age or Older",
    "officialTitle": "Multi-Centric Screening of Breast Cancer Patients to Determine Efficiency and to Assess Sensitivity & Accuracy of Pandora CDx MammoAlertTM in Screening of Breast Cancer.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 2458,
    "primaryOutcomeMeasure": "Screening performance (i.e., sensitivity and specificity)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Ability to give informed consent. Written informed consent by the patient/patient's legally acceptable representative (LAR) for donating blood sample\n2. Documented absence of cancer (other than Breast Cancer)\n3. Documented (Mammography and/or Biopsy) diagnosis of Breast Cancer (IDC/ILC/DCIS ), any stage\n4. Blood sample taken before any treatment for Breast Cancer was administered to the subject.\n\nExclusion Criteria:\n\n1. Other malignancy besides breast cancer in the 5 years prior to obtaining the sample.\n2. Therapies for breast cancer that have been administered within 1 year of obtaining the sample\n3. Any condition (including psychiatric), which in the Investigator's opinion, places the patient at undue risk by participating in the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}